Celularity (CELU) EBITDA (2018 - 2025)
Celularity (CELU) EBITDA from Sep 30, 2018 to Dec 31, 2025. The TTM Celularity (CELU) EBITDA is -$54M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Celularity (CELU) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +77.49% |
| 3 Years TTM | +49.51% |
| 5 Years TTM | -17.78% |
Annual EBITDA change of Celularity (CELU)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$54M | +77.43% |
| 2024 | -$30M | -83.36% |
| 2023 | -$183M | +1032.18% |
| 2022 | -$16M | -83.88% |
| 2021 | -$100M | -30.27% |
| 2020 | -$144M | -4620.44% |
| 2019 | $3.18M | N/A |
| 2018 | $0 | N/A |
Comparison Celularity (CELU) five years EBITDA CAGR with competitors
Celularity (CELU) five years EBITDA CAGR is -17.78%.